Physician profile
Catherine Elyse Dennis
NPI 1376137570
$919.73
in general payments reported to CMS, 2019-2025
17 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8.41 · 2022: $188 · 2023: $198 · 2024: $155 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $409.17 | 2022-2025 | |
| Novo Nordisk INC | $122.17 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $55.93 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $51.02 | 2023-2025 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $40.35 | 2025 | |
| Corcept Therapeutics | $35.59 | 2025 | Korlym |
| Lilly USA, LLC | $33.27 | 2022-2025 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $27.87 | 2025 | Rexulti |
| Lundbeck LLC | $20.89 | 2025 | Rexulti |
| Verona Pharma, INC. | $18.77 | 2025 | Ohtuvayre |
| Ars Pharmaceuticals Operations, INC. | $18.45 | 2025 | Neffy |
| Amgen INC. | $17.30 | 2025 | Evenity |
| Exact Sciences Corporation | $16.32 | 2024 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $15.30 | 2025 | Nuzyra |
| Shield Therapeutics INC | $15.15 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $13.77 | 2025 | Ibsrela |
| Genentech USA, INC. | $8.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Dennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.